search button

Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients.

  • Authors:
    • M Orditura
    • F De Vita
    • A Belli
    • F Ciaramella
    • M Musicò
    • A Ferrigno
    • R Formato
    • G Abbate
    • M R Diadema
    • G Catalano

  • View Affiliations

  • Published online on: March 1, 2000     https://doi.org/10.3892/or.7.2.397
  • Pages: 397-797
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to assess the protective effect and the safety profile of amifostine in 16 esophageal cancer patients undergoing neoadjuvant chemo-radiation therapy (group A) compared to 21 matched patients (group B), treated with the same schedule without receiving amifostine, and considered as controls. Haematological and extra-haematological toxicity were evaluated according to WHO criteria and considered as result of amifostine activity. The bone marrow toxicity was globally lower in group A than in group B. We recorded 4 cases of mucosities in group B compared to 1 case in group A. amifostine-related side effects were few (2 cases of hypotension and 1 of vomiting), mild, and well controlled. In conclusion, amifostine seems to be effective and safe when used as protective agent also in esophageal cancer.

Related Articles

Journal Cover

Mar-Apr 2000
Volume 7 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Orditura M, De Vita F, Belli A, Ciaramella F, Musicò M, Ferrigno A, Formato R, Abbate G, Diadema M, Catalano G, Catalano G, et al: Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients.. Oncol Rep 7: 397-797, 2000.
APA
Orditura, M., De Vita, F., Belli, A., Ciaramella, F., Musicò, M., Ferrigno, A. ... Catalano, G. (2000). Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients.. Oncology Reports, 7, 397-797. https://doi.org/10.3892/or.7.2.397
MLA
Orditura, M., De Vita, F., Belli, A., Ciaramella, F., Musicò, M., Ferrigno, A., Formato, R., Abbate, G., Diadema, M., Catalano, G."Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients.". Oncology Reports 7.2 (2000): 397-797.
Chicago
Orditura, M., De Vita, F., Belli, A., Ciaramella, F., Musicò, M., Ferrigno, A., Formato, R., Abbate, G., Diadema, M., Catalano, G."Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients.". Oncology Reports 7, no. 2 (2000): 397-797. https://doi.org/10.3892/or.7.2.397